PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $41 | +32.3% | 16 | 0.0% | 0.00% | – |
| Q2 2022 | $31 | -35.4% | 16 | 0.0% | 0.00% | – |
| Q1 2022 | $48 | -33.3% | 16 | 0.0% | 0.00% | – |
| Q4 2021 | $72 | -7.7% | 16 | 0.0% | 0.00% | – |
| Q3 2021 | $78 | -28.4% | 16 | 0.0% | 0.00% | – |
| Q2 2021 | $109 | -3.5% | 16 | 0.0% | 0.00% | – |
| Q1 2021 | $113 | +13.0% | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $100 | +14.9% | 16 | 0.0% | 0.00% | – |
| Q3 2020 | $87 | +3.6% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $84 | +68.0% | 16 | 0.0% | 0.00% | – |
| Q1 2020 | $50 | -21.9% | 16 | 0.0% | 0.00% | – |
| Q4 2019 | $64 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |